Jove
Visualize
Contact Us

Related Experiment Videos

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology.

Andrea Pellagatti1, Noor Esoof, Fiona Watkins

  • 1Leukaemia Research Fund Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK.

British Journal of Haematology
|May 19, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin rewiring of β-globin and MYC enhancers by TGF-β1 drives defective erythropoiesis.

Nature communications·2026
Same author

Variants in the CxxC domain of the epigenetic regulator KDM2B support its role in developmental eye anomalies.

European journal of human genetics : EJHG·2026
Same author

Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.

Cell reports·2025
Same author

Induced pluripotent stem cell-based modelling of disease evolution in myeloid leukemia: MDS to AML.

Advances in biological regulation·2025
Same author

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.

Blood·2025
Same author

Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromes.

The Journal of clinical investigation·2025
Same journal

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Immortal time bias limits the conclusion that post-transplant hypomethylating agent maintenance improves outcomes in myelodysplastic syndromes.

British journal of haematology·2026
Same journal

Author response to Zhang and Chen.

British journal of haematology·2026
Same journal

Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

British journal of haematology·2026
Same journal

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

British journal of haematology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
This summary is machine-generated.

Myelodysplastic syndromes (MDS) involve myeloid lineage clonal disorders. Gene expression profiling in neutrophils revealed significant heterogeneity and identified key up/down-regulated genes, aiding in MDS subtype discrimination.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders affecting myeloid lineage cells.
  • MDS presents with significant clinical and genetic heterogeneity.

Purpose of the Study:

  • To investigate gene expression profiles in neutrophils from MDS patients.
  • To identify differentially expressed genes in MDS subtypes and compare them to acute myeloid leukemia (AML).
  • To discover gene expression signatures that can differentiate specific MDS subtypes, such as the 5q- syndrome.

Main Methods:

  • Utilized cDNA microarrays with 6000 human genes to analyze neutrophil gene expression.
  • Compared gene expression profiles of 21 MDS patients (including 7 with 5q- syndrome) and 2 AML patients against healthy controls.

Related Experiment Videos

  • Validated microarray findings using real-time quantitative polymerase chain reaction (RT-qPCR).

    • Main Results:

    • Observed high heterogeneity in gene expression among MDS patients, reflecting underlying genetic diversity.
    • Identified commonly up-regulated genes (RAB20, ARG1, ZNF183, ACPL) and down-regulated genes (COX2, CD18, FOS, IL7R) in MDS.
    • Discovered specific gene expression patterns distinguishing the 5q- syndrome from refractory anemia with normal karyotype.

    Conclusions:

    • Gene expression profiling in neutrophils provides insights into MDS pathophysiology.
    • Identified MDS-specific gene expression changes with potential biological significance.
    • Differential gene expression analysis can aid in classifying MDS subtypes and potentially inform diagnostic strategies.